Vida Ventures Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-407,499
| Closed | -$9.6M | – | 5 |
|
|
2024
Q4 | $9.6M | Hold |
407,499
| – | – | 6.56% | 4 |
|
|
2024
Q3 | $14.6M | Hold |
407,499
| – | – | 10.56% | 4 |
|
|
2024
Q2 | $14.4M | Hold |
407,499
| – | – | 15.73% | 3 |
|
|
2024
Q1 | $11.6M | Sell |
407,499
-1,667,288
| -80% | -$47.3M | 6.43% | 3 |
|
|
2023
Q4 | $27.6M | Sell |
2,074,787
-145,247
| -7% | -$1.93M | 32.85% | 2 |
|
|
2023
Q3 | $19.9M | Hold |
2,220,034
| – | – | 30.79% | 2 |
|
|
2023
Q2 | $25M | Hold |
2,220,034
| – | – | 32.61% | 1 |
|
|
2023
Q1 | $25.6M | Hold |
2,220,034
| – | – | 34.99% | 1 |
|
|
2022
Q4 | $25.7M | Hold |
2,220,034
| – | – | 34.58% | 1 |
|
|
2022
Q3 | $28.2M | Sell |
2,220,034
-740,012
| -25% | -$9.4M | 25.3% | 1 |
|
|
2022
Q2 | $20.3M | Hold |
2,960,046
| – | – | 17.18% | 3 |
|
|
2022
Q1 | $28.5M | Hold |
2,960,046
| – | – | 16.6% | 4 |
|
|
2021
Q4 | $35.2M | Hold |
2,960,046
| – | – | 13.17% | 5 |
|
|
2021
Q3 | $48.1M | Hold |
2,960,046
| – | – | 13.77% | 5 |
|
|
2021
Q2 | $62.3M | Hold |
2,960,046
| – | – | 15.62% | 4 |
|
|
2021
Q1 | $46M | Hold |
2,960,046
| – | – | 11.61% | 5 |
|
|
2020
Q4 | $62.2M | Hold |
2,960,046
| – | – | 12.76% | 4 |
|
|
2020
Q3 | $59.8M | Buy |
+2,960,046
| New | +$59.8M | 37.43% | 2 |
|